» Authors » Anton J L M van Balkom

Anton J L M van Balkom

Explore the profile of Anton J L M van Balkom including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 167
Citations 2832
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wolf N, van Oppen P, Hoogendoorn A, van den Heuvel O, van Megen H, Broekhuizen A, et al.
Psychother Psychosom . 2024 Oct; 93(6):397-411. PMID: 39427635
Introduction: Although cognitive behavioral therapy (CBT) effectively treats obsessive-compulsive disorder (OCD), many patients refuse CBT or drop out prematurely, partly because of anxiety regarding exposure and response prevention (ERP) exercises....
2.
de Joode N, van den Heuvel O, Koster M, Clarke W, van Balkom A, Schrantee A, et al.
J Affect Disord . 2024 Sep; 367:416-425. PMID: 39233246
Obsessive-compulsive disorder (OCD) is linked with dysfunction in frontal-striatal, fronto-limbic, and visual brain regions. Research using proton magnetic resonance spectroscopy (H-MRS) suggests that altered neurometabolite levels, like glutamate, may contribute...
3.
Remmerswaal K, Batelaan N, van Oppen P, Scholten W, van Balkom A
J Psychiatr Pract . 2024 Jul; 30(4):297-307. PMID: 39058530
Objective: To test a multifaceted treatment program for patients with obsessive-compulsive disorder (OCD) who did not respond to regular cognitive behavior therapy (CBT). The treatment addresses several factors that may...
4.
Aggarwal N, Sadaghiyani S, Kananian S, Lam P, Messner G, Marincowitz C, et al.
Cult Med Psychiatry . 2024 Jun; 48(3):591-613. PMID: 38898162
Obsessive-compulsive disorder (OCD) is a condition with high patient morbidity and mortality. Research shows that eliciting patient explanations about illness causes and treatment preferences promotes cross-cultural work and engagement in...
5.
Rahsepar Meadi M, Bernstein J, Batelaan N, van Balkom A, Metselaar S
Bioethics . 2024 May; 38(6):503-510. PMID: 38735049
Mental health chatbots (MHCBs) designed to support individuals in coping with mental health issues are rapidly advancing. Currently, these MHCBs are predominantly used in commercial rather than clinical contexts, but...
6.
Setkowski K, van Balkom A, Hoogendoorn A, Franx G, Veerbeek M, de Winter R, et al.
Front Psychiatry . 2024 May; 15:1080235. PMID: 38707617
Objective: In 2016, the SUicide PRevention Action NETwork (SUPRANET) was launched. The SUPRANET intervention aims at better implementing the suicide prevention guideline. An implementation study was developed to evaluate the...
7.
van Balkom A, Beeres M, Scholten W
Ned Tijdschr Geneeskd . 2024 Feb; 168. PMID: 38415705
In this article, we will address 10 questions about anxiety that are relevant to doctors who encounter this in their practice. This often occurs in the primary care setting, where...
8.
Domschke K, Seuling P, Schiele M, Bandelow B, Batelaan N, Bokma W, et al.
World Psychiatry . 2024 Jan; 23(1):113-123. PMID: 38214637
Anxiety disorders are very prevalent and often persistent mental disorders, with a considerable rate of treatment resistance which requires regulatory clinical trials of innovative therapeutic interventions. However, an explicit definition...
9.
Waumans R, Muntingh A, Veldwijk J, Hoogendoorn A, van Balkom A, Batelaan N
Appl Health Econ Health Policy . 2023 Dec; 22(3):401-413. PMID: 38109008
Background: Depression in adolescents and young adults is common and causes considerable disease burden while hampering their development, leading to adverse consequences in later life. Although treatment is available, young...
10.
Waumans R, Muntingh A, Batelaan N, van Balkom A
Front Psychiatry . 2023 Dec; 14:1174285. PMID: 38076685
Dropout from psychological or pharmacological treatment for anxiety and depressive disorders is common. It is especially problematic in adolescents and young adults because of the adverse consequences for their development....